Opto

Rewiring Brain Health Through Bioelectronics

Founded by former engineering PhD students Ben Woodington and Elise Jenkins, Opto is creating a future where brain disorders can be diagnosed and treated faster, more accurately, and with less risk.

Their minimally invasive neural interface technology aims to revolutionise how we monitor and manage hard-to-treat neurological conditions—starting with glioblastoma, one of the most aggressive forms of brain cancer.

With £1.85M in pre-seed funding led by Blackbird Ventures and joined by Possible Ventures and angel investors like Amar Shah (Wayve Technologies), Opto is accelerating towards real-world clinical impact.

Why Opto Is a Great Place to Work

A Mission That Matters Opto isn’t just a bioelectronics company, they’re giving clinicians new tools to understand and treat brain diseases in real time. If you want to work on technology that could save or extend lives, this is it.

At the Edge of Science The company grew out of world-leading research at the University of Cambridge’s Bioelectronics Lab and has since attracted global collaborators and clinical advisors. Opto is turning deep academic insight into practical, life-changing tools.

Engineering with Purpose The team is focused on miniaturised implantable sensors that can be inserted without major surgery or overnight hospital stays. It’s not just technical excellence, it’s engineering designed for accessibility, safety, and real-world application.

Backed by Visionaries With backing from Blackbird Ventures and other top investors, Opto has the resources and support to build something ambitious from day one. Investors were drawn to the team's rare mix of technical talent and user obsession.

Inspired Leadership Ben and Elise are scientists and engineers, but they’re also deeply motivated by patients, clinicians, and the gaps in care they’re working to close. Their hands-on collaboration with neurosurgeons worldwide makes working at Opto feel personal and high impact.

If you’re passionate about applying cutting-edge technology to real-world healthcare challenges, Opto is building the future of brain monitoring and treatment. Join the team reshaping what’s possible in neuroscience and medical diagnostics.